Project Description
Granules India Limited (“Granules” or the “Company”)— an existing IFC client— is a leading Contract Manufacturing Organization supplying high volume Active Pharmaceutical Ingredients, Pharmaceutical Formulation Intermediates (PFIs) and finished formulations to the bulk over-the-counter drugs industry in the US, Europe, Latin America, Australia and India. Granules has three wholly-owned manufacturing plants near Hyderabad in India (Jeedimetla, Bonthapally, and Gagillapur) and one plant in China through a 50:50 joint venture.
The company is undertaking an investment program (the “Project”) estimated to cost about $22 million, comprising of: expanding the capacity of its multi-product tableting plant, expanding the capacity of its PFI plant and expanding its warehousing capacity.